HilleVax, Inc (HLVX)
NASDAQ:HLVX
US Market

HilleVax, Inc (HLVX) Stock Price & Analysis

7 Followers

HLVX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.90 - $24.42
Previous Close$18
Volume606.00
Average Volume (3M)87.45K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-3.1
Beta0.04
Next EarningsNov 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-5.75
Shares Outstanding33,345,260
R-Squared0.00079
Standard Deviation0.27
10 Day Avg. Volume28,884
30 Day Avg. Volume87,455
Price to Book (P/B)1.99
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-12.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Alpha0.02
Number of Analyst Covering1


HLVX FAQ

What was HilleVax, Inc’s price range in the past 12 months?
HilleVax, Inc lowest stock price was $7.90 and its highest was $24.42 in the past 12 months.
    What is HilleVax, Inc’s market cap?
    Currently, no data Available
    When is HilleVax, Inc’s upcoming earnings report date?
    HilleVax, Inc’s upcoming earnings report date is Nov 10, 2022 which is 85 days ago.
      How were HilleVax, Inc’s earnings last quarter?
      HilleVax, Inc released its earnings results on Aug 10, 2022. The company reported -$2.03 earnings per share for the quarter, missing the consensus estimate of -$0.772 by -$1.258.
        Is HilleVax, Inc overvalued?
        According to Wall Street analysts HilleVax, Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does HilleVax, Inc pay dividends?
          HilleVax, Inc does not currently pay dividends.
          What is HilleVax, Inc’s EPS estimate?
          HilleVax, Inc’s EPS estimate is -$0.9.
            How many shares outstanding does HilleVax, Inc have?
            HilleVax, Inc has 33,345,260 shares outstanding.
              What happened to HilleVax, Inc’s price movement after its last earnings report?
              HilleVax, Inc reported an EPS of -$2.03 in its last earnings report, missing expectations of -$0.772. Following the earnings report the stock price went down -7.902%.
                Which hedge fund is a major shareholder of HilleVax, Inc?
                Among the largest hedge funds holding HilleVax, Inc’s share is Deerfield Management Company, LP. It holds HilleVax, Inc’s shares valued at 45M.

                  ---

                  HilleVax, Inc Stock Smart Score

                  The HilleVax, Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  HilleVax, Inc

                  HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Tango Therapeutics
                  Bluebird Bio
                  Avidity Biosciences
                  Alector
                  Century Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis